TY  - JOUR

T1  - Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example

JO  - Molecular Cancer Therapeutics

UR  - https://doi.org/10.1158/1535-7163.mct-17-0262

PY  - 2018/02/01

AU  - Eke I

AU  - Makinde AY

AU  - Aryankalayil MJ

AU  - Sandfort V

AU  - Palayoor ST

AU  - Rath BH

AU  - Liotta L

AU  - Pierobon M

AU  - Petricoin EF

AU  - Brown MF

AU  - Stommel JM et al

ED  - 

DO  - DOI: 10.1158/1535-7163.mct-17-0262

PB  - American Association for Cancer Research (AACR)

VL  - 17

IS  - 2

SP  - 355

EP  - 367

Y2  - 2026/03/17

ER  -